Remission of HBV-related mesangioproliferative glomerulonephritis after interferon therapy.
Dhiman
R K
RK
Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kohli
H S
HS
Das
G
G
Joshi
K
K
Chawla
Y
Y
Sakhuja
V
V
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D005500:Follow-Up Studies; D015432:Glomerulonephritis, Membranoproliferative / Q000209:etiology* / Q000628:therapy*; D006509:Hepatitis B / Q000150:complications* / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011507:Proteinuria; D011994:Recombinant Proteins; D012709:Serum Albumin / Q000032:analysis
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012709:Serum Albumin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase